Option chain shows key data for Mill City Ventures III's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Mill City Ventures III.

Mill City Ventures III (NASDAQ:MCVT) Stock, Option Chain

Mill City Ventures III

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

As More Consumers And Investors Seek Alternative Financing, This Company’s Specialty Financing Could Provide Answers

Penny Stocks

Markets

GROW

LOAN

MCVT

OXSQ

A wind of change is blowing through the financial industry as more people drift toward nonbank institutions for their borrowing needs.

As More Consumers And Investors Seek Alternative Financing, This Company&#39;s Specialty Financing Could Provide Answers

News

Small Cap

Pre-Market Outlook

Movers

Trading Ideas

ABMD

ACOR

AGLE

AMBO

ANEB

ARAV

ARBK

ATAI

BAOS

BCOR

BCRX

CABA

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CLEU

COEP

CTLT

CVNA

CYXT

HGEN

HLIT

HOLX

HRMY

HTHT

ICPT

IDBA

IDXX

IRNT

KFRC

KIDS

KNSA

LEJU

LSCC

LYFT

MNSO

MYGN

NKLA

NLSP

PERF

PHAR

RETO

SatixFy Communications Ltd. Ordinary Share

SATX

SFET

SLNA

SNOA

SOFI

SONN

STRY

TCOM

TEDU

TRNS

UBER

UXIN

VRNS

VYNT

ZBRA

ZLAB

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday

This Company’s Uplisting Could Be A Catalyst For Further Growth As It Reports Q2 Financial Results

Movers & Shakers

General

NDAQ

Learn more about Mill City Ventures III, Ltd. by gaining access to the latest research report. 

Going public on bigger markets gives private companies a perfect opportunity to generate capital to help further growth, reduce debt, fund research and development (R&amp;D) and take care of other business operations.

This Company&#39;s Uplisting Could Be A Catalyst For Further Growth As It Reports Q2 Financial Results

Mill City Ventures III, Ltd. - Common Stock

Mill City Ventures III Ltd

Mill City Ventures Announces Amendment To Loan Agreement With Mustang Funding, Annual Rate Has Been Revised To 20%, With 15% Payable In Cash Monthly And 5% Deferred Until Maturity Or Earlier Acceleration

<h3>Gainers</h3>
<ul>
<li>B. Riley Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) shares increased by 15.2% to $4.55 during Tuesday's pre-market session. The market value of their outstanding shares is at $137.8 million. </li>
<li>AtlasClear Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#AMEX">ATCH</a>) shares increased by 14.7% to $8.58. The company's market cap stands at $3.3 million. </li>
<li>OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) stock moved upwards by 9.6% to $1.94. The market value of their outstanding shares is at $4.1 million. </li>
<li>TOP Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOP#NASDAQ">TOP</a>) shares rose 7.74% to $1.53. The company's market cap stands at $56.6 million. </li>
<li>Hancock Whitney Corporation - 6.25% Subordinated Notes due 2060 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWCPZ#NASDAQ">HWCPZ</a>) shares moved upwards by 7.52% to $25.0. </li>
<li>Future FinTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) shares increased by 7.43% to $0.29. The company's market cap stands at $6.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) shares decreased by 12.8% to $2.79 during Tuesday's pre-market session. The market value of their outstanding shares is at $17.8 million. </li>
<li>Greenpro Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) shares fell 12.6% to $1.11. The market value of their outstanding shares is at $8.4 million. </li>
<li>AvidXchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) stock decreased by 9.85% to $8.7. The company's market cap stands at $1.7 billion. </li>
<li>Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) shares declined by 9.46% to $6.61. The company's market cap stands at $571.1 million. </li>
<li>First of Long Island (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLIC#NASDAQ">FLIC</a>) shares decreased by 8.52% to $10.21. The market value of their outstanding shares is at $230.1 million. </li>
<li>Riverview Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>) shares declined by 8.25% to $5.01. The company's market cap stands at $105.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATCH

AVDX

FLIC

FTFT

GRNQ

Hancock Whitney Corporation - 6.25% Subordinated Notes due 2060

HWCPZ

RILY

RPAY

RVSB

12 Financials Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>XChange Tec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) shares moved upwards by 25.7% to $1.42 during Monday's pre-market session. The market value of their outstanding shares is at $159.9 million. </li>
<li>Palmer Square Capital BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSBD#NYSE">PSBD</a>) shares moved upwards by 12.24% to $17.0. The market value of their outstanding shares is at $555.1 million. </li>
<li>DigiAsia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) stock moved upwards by 11.81% to $1.23. The company's market cap stands at $74.6 million. </li>
<li>Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) shares increased by 11.14% to $3.59. The market value of their outstanding shares is at $22.9 million. </li>
<li>P10 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) shares rose 10.07% to $13.99. The company's market cap stands at $1.5 billion. </li>
<li>Greenpro Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) shares rose 10.05% to $2.08. The company's market cap stands at $15.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Guild Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) stock declined by 17.2% to $10.3 during Monday's pre-market session. The company's market cap stands at $637.4 million. </li>
<li>RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) shares declined by 11.29% to $221.83. The market value of their outstanding shares is at $11.5 billion. </li>
<li>Mercury General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCY#NYSE">MCY</a>) shares decreased by 9.53% to $44.0. The market value of their outstanding shares is at $2.4 billion. </li>
<li>Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) shares declined by 8.5% to $8.51. The market value of their outstanding shares is at $549.9 million. </li>
<li>Heritage Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTBK#NASDAQ">HTBK</a>) stock fell 8.46% to $8.01. The market value of their outstanding shares is at $490.9 million. </li>
<li>FB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBLA#NASDAQ">FBLA</a>) stock fell 7.61% to $10.2. The company's market cap stands at $202.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAAS

FBLA

GHLD

HTBK

PSBD

VINP

12 Financials Stocks Moving In Monday's Pre-Market Session

Mill City Ventures III Shares Halted On Circuit Breaker To The Downside, Stock Now Down -33.8%

Buybacks

Mill City Ventures Announces $2M Stock Repurchase Program

Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) reported quarterly earnings of $0.06 per share. This is a 500 percent increase over earnings of $0.01 per share from the same period last year. The company reported $888.63 thousand in sales this quarter. This is a 2.08 percent decrease over sales of $907.50 thousand the same period last year.

Earnings

Mill City Ventures III Q2 EPS $0.06 Up From $0.01 YoY, Sales $888.63K Down From $907.50K YoY

Mill City Ventures III On Aug. 14 Reported Q2 EPS $0.06 Up From $0.01 YoY

WIIM

ACGL

AGNC

ARES

BBAR

BBDO

CRBG

ITUB

TREE

Shares of financial stocks are trading higher amid overall market strength after the fed maintained interest rates at current levels.

Mill City Ventures III Audited Consolidated Financial Statements For Period Ended Dec 31, 2022 Should No Longer Be Relied Upon

Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) reported $847.52 thousand in sales this quarter. This is a 24.96 percent increase over sales of $678.21 thousand the same period last year.
2022 Highlights
<ul>
<li>Investment income from lending operations increased&nbsp;24.9%&nbsp;to&nbsp;$847,518&nbsp;in the three-month period ended December 31, 2022, from&nbsp;$678,209&nbsp;in the prior year period. For the 2022 full year, investment income was&nbsp;$4,199,453&nbsp;compared to&nbsp;$2,656,201&nbsp;in 2021, a&nbsp;$1,543,252&nbsp;or&nbsp;58%&nbsp;increase.</li>
<li>Pre-tax earnings from lending operations were&nbsp;$316,506&nbsp;in the three-month period ended December 31, 2022, compared to&nbsp;$347,054&nbsp;in the prior year period. For the 2022 full year, net gain from lending operations increased to&nbsp;$1,440,576&nbsp;from&nbsp;$1,301,450, a&nbsp;$139,126&nbsp;or&nbsp;10.6%&nbsp;increase.
<ul>
<li>Shareholder equity increased to&nbsp;$18,342,339&nbsp;from&nbsp;$13,414,048&nbsp;at December 31, 2021.</li>
</ul>
</li>
</ul>

Mill City Ventures III Q4 Sales $847.52K Up From $678.21K YoY; Investment Income From Lending Operations Increases 58%; Shareholder Equity Increases 36.7%

<h3>Gainers</h3>
<ul>
<li>World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) stock moved upwards by 22.9% to $99.57 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 134.7K, which is 154.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $623.0 million. As per the press release, Q3 earnings came out today. </li>
<li>Metalpha Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) stock rose 14.35% to $0.58. The market value of their outstanding shares is at $15.5 million. </li>
<li>LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) shares rose 9.89% to $35.27. Trading volume for this security as of 12:30 EST is 183.5K, which is 66.2% of its average full-day volume over the last 100 days. The company's market cap stands at $451.0 million. </li>
<li>Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) shares rose 9.65% to $2.51. The company's market cap stands at $15.5 million. </li>
<li>Value Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALU#NASDAQ">VALU</a>) shares rose 8.93% to $54.35. The market value of their outstanding shares is at $513.6 million. </li>
<li>Pintec Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PT#NASDAQ">PT</a>) stock increased by 8.57% to $0.38. The company's market cap stands at $3.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) shares fell 19.1% to $25.75 during Thursday's regular session. Trading volume for Customers Bancorp's stock is 1.1 million as of 12:30 EST. This is 347.2% of its average full-day volume over the last 100 days. The company's market cap stands at $837.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alvarium Tiedemann Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) shares declined by 12.8% to $13.43. The current volume of 179.8K shares is 95.9% of Alvarium Tiedemann Hldgs's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $737.2 million. </li>
<li>LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) stock declined by 12.09% to $9.09. LendingClub's stock is trading at a volume of 4.6 million shares as of 12:30 EST. This is 270.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $955.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alerus Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) stock fell 9.65% to $20.33. The current volume of 65.1K shares is 212.6% of Alerus Finl's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $406.3 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>ConnectOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNOB#NASDAQ">CNOB</a>) shares decreased by 9.64% to $22.07. The current volume of 189.1K shares is 142.7% of ConnectOne Bancorp's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $866.2 million. As per the news, the Q4 earnings report came out today. </li>
<li>Kearny Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNY#NASDAQ">KRNY</a>) stock decreased by 9.02% to $9.4. Kearny Financial's stock is trading at a volume of 134.7K shares as of 12:30 EST. This is 52.7% of its average full-day volume over the last 100 days. The company's market cap stands at $635.0 million. The company's, Q2 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALRS

ALTI

CNOB

CUBI

KRNY

MATH

VALU

WRLD

12 Financials Stocks Moving In Thursday's Intraday Session

COIN

EHTH

FRBK

GOCO

MSCI

NCPL

OPRT

THCH

TROW

Shares of banks and financial services companies are trading higher on continued hopes of a peaking labor market and potentially slowed inflation following Friday economic data. Softer inflation could lead to less aggressive Fed monetary policy and positively impact lending.

Mill City Ventures III Shares Resume Trading; Shares Down ~2% Premarket

Mill City Ventures III, Ltd. Shares To Resume At 7:30 a.m. ET

Mill City Ventures III, Ltd. (&quot;Mill City&quot;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>), a specialty short-term finance and non-bank lender, announced today that it has entered into a non-binding letter of intent for a merger transaction with Mustang Funding, LLC dba Mustang Litigation Funding (&quot;Mustang&quot;), a Delaware limited liability company owning and operating a Minneapolis-based litigation finance business focusing on the long-term capital needs of law firms, plaintiffs and vendors. Mustang has associated offices in Plymouth Meeting, Pennsylvania and Sarasota, Florida. The letter of intent contemplates Mill City&#39;s acquisition of Mustang through a legal structure that is to be determined in connection with reaching a definitive agreement, but with the owners of Mustang receiving a sufficient number of shares of Mill City common stock such that they would own&nbsp;80%&nbsp;of the total number of issued and outstanding shares of Mill City common stock on a post-transaction basis. The letter of intent is non-binding and obligates the parties only to work cooperatively and in good faith for the purpose of negotiating and entering into a definitive agreement governing the transaction.
The letter of intent sets forth certain conditions precedent to any closing of the transaction, and a definitive agreement, if reached, would likely set forth additional customary and negotiated conditions to any such closing. The conditions identified in the letter of intent include the completion of due diligence to the satisfaction of the both parties, a financing-based condition, the consummation of a short-term loan by Mill City to Mustang, the approval of the owners of Mustang and the shareholders of Mill City, together with any related regulatory approvals that may be required, including any required approval by Nasdaq of the continued listing of Mill City common stock after any closing. Any definitive agreement that may be reached is expected to contain other customary and negotiated terms and conditions, and may contain terms and conditions different from those contemplated in the letter of intent.

Mill City Ventures III, Ltd. Enters Into Letter Of Intent To Acquire Mustang Funding, LLC

Mill City Ventures III, Ltd. Shares Halted, News Pending

&nbsp;Mill City Ventures III, Ltd.&nbsp;<a href="https://pr.report/nG02jLR3">(NASDAQ:</a><a href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) (&quot;Mill City&quot; or the &quot;Company&quot;) a non-bank lender and specialty finance company, today announced financial results for the three-month and nine-month periods ended September 30, 2022.
3Q 2022 Highlights
<ul>
<li>Investment income from lending operations increased&nbsp;47.5%&nbsp;to&nbsp;$1,115,224&nbsp;in the three-month period ended September 30, 2022, from&nbsp;$755,601&nbsp;in the prior year period. For the nine-month period, investment income was&nbsp;$3,351,935&nbsp;compared to&nbsp;$1,977,992&nbsp;in the prior year period, a&nbsp;69%&nbsp;increase.</li>
<li>Net loss in the&nbsp;third quarter&nbsp;was ($64,568) compared to a gain of&nbsp;$516,019&nbsp;in the prior year period. The loss in the&nbsp;third quarter&nbsp;was driven primarily by professional fees incurred during the quarter related to the Company&#39;s public offering and listing on Nasdaq. In the nine-month period, net gain from lending operations increased to&nbsp;$1,124,070&nbsp;from&nbsp;$954,396&nbsp;in the prior year period, a&nbsp;17.7%&nbsp;increase.</li>
<li>Shareholder equity increased to&nbsp;$18,658,595&nbsp;from&nbsp;$13,414,049&nbsp;at December 31, 2021</li>
<li>At September 30, 2022, the Company had&nbsp;$1,861,650&nbsp;in cash, compared with&nbsp;$1,936,148&nbsp;at December 31, 2021.</li>
</ul>
Commenting on the quarter, Chief Executive Officer Douglas M. Polinsky said, &quot;Our&nbsp;third quarter&nbsp;results reflect the continued robust demand for our short-term loans as income from operations increased on a three-month and nine-month basis. Our net results include professional fees we incurred in connection with our public offering and uplisting to Nasdaq in August, and as part of our efforts to raise our visibility with the investment community and grow our business. The market demand for our lending solutions continues to be the main driver our growth, and we intend to remain opportunistic about acquisitions that may accelerate that growth.&quot;

Mill City Ventures III Reports 2022 Q3 Financial Results Investment Income From Lending Operations Increases 47.5% To $1,115,224 Shareholder Equity Increases 39%

Mill City Ventures III, Ltd. (&ldquo;Mill City&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) announced today its funding of a settled insurance claim in the amount of&nbsp;$855,000.&nbsp;&nbsp;The related short-term note is expected to mature in 120 days and involve an annualized return of&nbsp;33.5%.
Mill City Chief Executive Officer, Douglas M. Polinsky, said, &ldquo;This latest closing is one more example of our ability to profitably service a growing need in the financing markets. With rising inflation and rapidly rising interest rates, borrowers are facing an increasing number of hurdles to clear in their efforts to access capital on a short-term basis.&nbsp;&nbsp;There continues to be a large funding gap between the needs of small- and medium-sized businesses and the institution-based financing available to them.&nbsp;&nbsp;Our ability to quickly create financing solutions for a variety of needs is proving to be a significant growth engine for Mill City Ventures.&rdquo;

Legal

Mill City Funds $855,000 Short-Term Insurance Settlement

A wind of change is blowing through the financial industry as more people drift toward nonbank institutions for their borrowing needs.
In 1974, banks&nbsp;<a href="https://www.fdic.gov/analysis/quarterly-banking-profile/fdic-quarterly/2019-vol13-4/fdic-v13n4-3q2019-article1.pdf">controlled</a>&nbsp;the lending industry, holding 62% of the total loans. Almost five decades later, nonbanks&nbsp;<a href="https://www.wsj.com/articles/nonbank-lenders-are-dominating-the-mortgage-market-11624367460?mod=business_lead_pos6">issued</a>&nbsp;68% of all U.S. mortgages.&nbsp;
A report by the&nbsp;<a href="https://www.bis.org/publ/qtrpdf/r_qt2203c.htm#:~:text=Total%20new%20syndicated%20lending%20to,%2C%20left%2Dhand%20panel).">Bank for International Settlements (BIS)</a>&nbsp;indicated that syndicated lending to nonfinancial corporations increased substantially, from less than $300 billion in 1990 to around $4.75 trillion in 2019. Nonbank lending increased from $20 billion to $410 billion per year over the same period.
<h2>Specialty Financing</h2>
These nonbanks&rsquo; ability to meet the need for alternative or specialty financing may be what&rsquo;s driving their increase in lending.
Specialty finance firms make it easier for consumers and small to mid-size businesses to get loans they may find difficult to obtain from traditional banks.
They have easily won the hearts of some customers who were yearning to bypass long bureaucratic processes in favor of more straightforward procedures like completing loan applications and payments digitally with no initial fees and low-interest rates.
Thanks to this financing option, people who do not qualify for a traditional bank loan because of bad credit history are now turning to the alternative lending market for their capital needs.
In this context, companies like Oxford Square Capital Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxsq#NASDAQ">OXSQ</a>), Mill City Ventures III Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>), Manhattan Bridge Capital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/loan#NASDAQ">LOAN</a>), and U.S. Global Investors (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grow#NASDAQ">GROW</a>) have flourished over recent years.
<h2>Meeting Demand</h2>
As borrowers continue seeking alternative financing sources, <a href="https://www.millcityventures3.com/">Mill City Ventures III Ltd</a>, a short-term nonbank lending and specialty finance company could be answering this demand with its specialty financing solutions
Founded in January 2006,&nbsp;Mill City specialized in providing bespoke short-term lending solutions to public and private companies facing short-term liquidity issues.&nbsp;
Mill City ordinarily provides nonbank lending and specialty finance to companies and individuals with both collateral and a short-term source of liquidity anticipated to be available by the time the loan matures. The principal specialty finance solutions the company provides are high-interest, short-term lending arrangements.
The loans the company provides typically have maturities of nine months or less and involve a pledge of collateral or, in the case of loans made to companies, personal guarantees by the borrower&rsquo;s principals.
Since commencing short-term nonbank lending operations in January 2020, both the average loan size and weighted interest rate have increased year over year.
<a href="https://profiles.smallcapsdaily.com/mcvt/"><img alt="screenshot_2022-11-02_at_5.52.58_pm.png" src="https://www.benzinga.com/files/u240220/screenshot_2022-11-02_at_5.52.58_pm.png" style="height:349px; width:650px" /></a>
<h2>Financials</h2>
The company&rsquo;s product offerings could be positively affecting growth, as shown in Mill City&rsquo;s recent&nbsp;<a href="https://www.benzinga.com/pressreleases/22/08/ac28513935/mill-city-ventures-iii-ltd-reports-2022-second-quarter-financial-results">financial results</a>&nbsp;for the three- and six-month periods that ended June 30, which could be good news for investors.
<h3>Q2 2022 Highlights</h3>
<ul>
<li>Investment income from lending operations increased 83% to $1.24 million in the three months ended June 30, up from $675,549 in the prior year.&nbsp;</li>
</ul>
For the six-month period, investment income from lending operations was $2.24 million, compared to $1.2 million at the same time a year ago, an 83% increase.
<ul>
<li>Pretax earnings from lending operations increased in the second quarter to $734,250 from $425,393 in the prior year, a 73% increase.&nbsp;</li>
<li>In the six-month period, pretax earnings from lending operations reached $1.2 million compared to $438,377 in the prior year period, a 171% increase.</li>
<li>Shareholder equity increased to $14.4 million on June 30, 2022, from $13.4 million on Dec. 31, 2021.</li>
<li>As of June 30, 2022, the company had $629,572 in cash, compared with $1,936,148 as of Dec. 31, 2021.</li>
</ul>
Featured photo by <a href="https://www.shutterstock.com/g/Kritchanut">Atstock Productions</a> on&nbsp; <a href="https://www.shutterstock.com/image-photo/close-businessman-hand-giving-money-russian-687049846">Shutterstock</a>
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

As More Consumers And Investors Seek Alternative Financing, This Company's Specialty Financing Could Provide Answers

<h3>Gainers</h3>
<ul>
<li>Abiomed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abmd#NASDAQ">ABMD</a>) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson &amp; Johnson announced it <a href="https://www.benzinga.com/quote/ABMD/analyst-ratings"> will acquire the company </a>. Also, the company reported better-than-expected Q2 adjusted EPS results.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonn#NASDAQ">SONN</a>) gained 46.6% to close at $2.83. Sonnet BioTherapeutics recently announced an agreement with Janssen for the evaluation of three Sonnet product candidates.</li>
<li>NLS Pharmaceutics AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nlsp#NASDAQ">NLSP</a>) gained 44% to settle at $0.74. NLS Pharmaceutics was granted FDA Orpha Drug Designation for Quilience (Mazindol) for the treatment of idiopathic hypersomnia.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) jumped 34.7% to close at $1.71.</li>
<li>Safe-T Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfet#NASDAQ">SFET</a>) shares gained 30.7% to close at $0.3921 on Tuesday as the company said its privacy application reached over 5,000,000 downloads.</li>
<li>Aravive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arav#NASDAQ">ARAV</a>) gained 30.5% to close at $1.71.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) jumped 25.1% to settle at $2.49.</li>
<li>Mill City Ventures III, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcvt#NASDAQ">MCVT</a>) gained 24.1% to close at $2.73.</li>
<li>IDEX Biometrics ASA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idba#NASDAQ">IDBA</a>) climbed 23% to close at $7.27.</li>
<li>Harsco Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hsc#NYSE">HSC</a>) climbed 22.5% to close at $6.48 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance.</li>
<li>Cabaletta Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caba#NASDAQ">CABA</a>) gained 21.9% to close at $2.06.</li>
<li>Baosheng Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baos#NASDAQ">BAOS</a>) rose 21.2% to close at $1.05.</li>
<li>Anebulo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aneb#NASDAQ">ANEB</a>) surged 20.3% to settle at $2.90.</li>
<li>Humanigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgen#NASDAQ">HGEN</a>) gained 19.9% to settle at $0.1680.</li>
<li>NantHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nh#NASDAQ">NH</a>) jumped 19.6% to close at $0.3886.</li>
<li>Tarena International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tedu#NASDAQ">TEDU</a>) gained 18.3% to settle at $5.49.</li>
<li>Leju Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leju#NYSE">LEJU</a>) rose 18.2% to close at $1.56.</li>
<li>IronNet, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irnt#NYSE">IRNT</a>) gained 17.4% to close at $0.8338. IronNet announced receipt of continued listing standard notice from NYSE.</li>
<li>Pharming Group N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phar#NASDAQ">PHAR</a>) gained 17.2% to close at $11.40.</li>
<li>Ambow Education Holding Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ambo#NYSE">AMBO</a>) surged 16.8% to close at $0.3038.</li>
<li>ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) climbed 16.4% to close at $0.6399.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) gained 14.6% to close at $3.38 after Loop Capital initiated coverage on the stock with a Buy rating and a $18 price target.</li>
<li>Harmony Biosciences Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrmy#NASDAQ">HRMY</a>) rose 14% to settle at $59.26 after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) gained 13.6% to close at $3.26. Community Health Systems recently posted a Q3 loss of $0.52 per share.</li>
<li>Intercept Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icpt#NASDAQ">ICPT</a>) jumped 13.4% to settle at $15.73 after the company reported better-than-expected Q3 sales results.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) gained 12.9% to close at $15.28 after JP Morgan upgraded the stock from Underweight to Neutral and announced a $20 price target.</li>
<li>Zai Lab Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zlab#NASDAQ">ZLAB</a>) shares jumped 12.3% to close at $25.02. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knsa#NASDAQ">KNSA</a>) climbed 12.1% to close at $12.80 after the company posted a profit for the third quarter.</li>
<li>Uber Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>) rose 12% to close at $29.75 after the company reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.</li>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) jumped 11.7% to close at $12.21. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>H World Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htht#NASDAQ">HTHT</a>) shares climbed 10.8% to close at $30.00.</li>
<li>MINISO Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NYSE">MNSO</a>) rose 10.4% to close at $5.63.</li>
<li>IDEXX Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idxx#NASDAQ">IDXX</a>) surged 9.8% to settle at $394.93 after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>RLX Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rlx#NYSE">RLX</a>) rose 9.6% to close at $1.37 after declining over 7% on Monday.</li>
<li>Hologic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holx#NASDAQ">HOLX</a>) rose 9.3% to close at $74.13 after the company reported better-than-expected Q3 EPS and sales results.</li>
<li>Trip.com Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcom#NASDAQ">TCOM</a>) shares gained 8.4% to settle at $24.54 amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>Lattice Semiconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lscc#NASDAQ">LSCC</a>) gained 8.4% to close at $52.58 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance above analyst estimates.</li>
<li>Aeglea BioTherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agle#NASDAQ">AGLE</a>) climbed 7.8% to close at $1.11. Wells Fargo recently upgraded the stock from Equal-Weight to Overweight and raised its price target from $1.5 to $2.</li>
<li>Cyxtera Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyxt#NASDAQ">CYXT</a>) gained 6.6% to close at $2.58.</li>
<li>Blucora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcor#NASDAQ">BCOR</a>) gained 6.1% to close at $23.37 after the company reported better-than-expected Q3 sales results and announced it sold TaxAct for $720 million in cash.</li>
<li>iQIYI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iq#NASDAQ">IQ</a>) rose 5.5% to close at $2.13. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China&#39;s &#39;Zero COVID&#39; policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.</li>
<li>SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) gained 5.3% to close at $5.73 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) gained 3.5% to close at $15.15 in sympathy with Uber, which reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.</li>
</ul>
&nbsp;
<h3>
Losers</h3>
<ul>
<li>Varonis Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrns#NASDAQ">VRNS</a>) shares fell 35.5% to close at $17.27 on Tuesday after the company reported worse-than-expected Q3 results.</li>
<li>Satixfy Communications Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/satx#NYSE">SATX</a>) dipped 29.4% to close at $11.51.</li>
<li>China Liberal Education Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cleu#NASDAQ">CLEU</a>) fell 27.4% to settle at $1.14.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares fell 25.2% to close at $0.8001 after jumping over 63% on Monday.</li>
<li>Catalent, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctlt#NYSE">CTLT</a>) fell 24.7% to close at $49.53 after the company reported worse-than-expected Q1 EPS and sales results and issued FY23 sales guidance below estimates.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) fell 22.9% to close at $9.94.</li>
<li>LMF Acquisition Opportunities, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icu#NASDAQ">ICU</a>) fell 22.1% to close at $8.48.</li>
<li>Coeptis Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coep#NASDAQ">COEP</a>) dropped 21.4% to close at $5.11. Coeptis Therapeutics announced closing of business combination with Bull Horn Holdings Corp.</li>
<li>Instil Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/til#NASDAQ">TIL</a>) fell 20.3% to settle at $2.63. Instil Bio voluntarily paused enrollment of its ongoing clinical trials. Cowen &amp; Co. downgraded Instil Bio from Outperform to Market Perform.</li>
<li>Solaris Oilfield Infrastructure, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/soi#NYSE">SOI</a>) fell 19.8% to settle at $10.92 following downbeat quarterly sales.</li>
<li>Vyant Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vynt#NASDAQ">VYNT</a>) fell 18.8% to close at $0.3799 after the company announced a one-for-five reverse stock split.</li>
<li>Starry Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stry#NYSE">STRY</a>) dropped 18.6% to close at $0.18. Citigroup recently downgraded the stock from Neutral to Sell and lowered its price target from $3.75 to $0.25.</li>
<li>TETRA Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tti#NYSE">TTI</a>) declined 18.2% to close at $4.04 following weak quarterly results.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) declined 18% to close at $0.9099. Argo Blockchain shares dipped around 44% on Monday after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be conssumated.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) dropped 17.9% to settle at $9.02.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) fell 17.3% to close at $2.35.</li>
<li>Clearwater Paper Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clw#NYSE">CLW</a>) declined 16.8% to close at $37.00 following Q3 results. RBC Capital downgraded Clearwater Paper from Outperform to Sector Perform.</li>
<li>Zebra Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zbra#NASDAQ">ZBRA</a>) dropped 15.9% to close at $238.30 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS guidance below analyst estimates.</li>
<li>Myriad Genetics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mygn#NASDAQ">MYGN</a>) fell 15.6% to close at $17.50 following downbeat Q3 results.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gt#NASDAQ">GT</a>) fell 14.9% to close at $10.81 after the company reported worse-than-expected Q3 earnings.</li>
<li>Transcat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trns#NASDAQ">TRNS</a>) dropped 12.8% to close at $72.13 following Q2 results.</li>
<li>Paragon 28, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fna#NYSE">FNA</a>) fell 12.8% to close at $17.41. Paragon 28 filed for mixed shelf of up to $100 million.</li>
<li>Uxin Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uxin#NASDAQ">UXIN</a>) dropped 12.6% to close at $3.60.</li>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcrx#NASDAQ">BCRX</a>) fell 11.2% to close at $11.86 after the company reported Q3 earnings results and issued FY22 guidance.</li>
<li>OrthoPediatrics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kids#NASDAQ">KIDS</a>) fell 10.7% to close at $37.96 after the company issued FY22 revenue guidance below estimates.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) declined 10.3% to settle at $3.40. Nikola recently announced a hydrogen supply collaboration with Keystate.</li>
<li>Harmonic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlit#NASDAQ">HLIT</a>) dropped 10.2% to close at $13.88 following Q3 results.</li>
<li>SeqLL Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sql#NASDAQ">SQL</a>) fell 10.1% to close at $0.5290.</li>
<li>Evolent Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evh#NYSE">EVH</a>) declined 9.1% to close at $28.93. Truist Securities initiated coverage on Evolent Health with a Hold rating and announced a price target of $33.</li>
<li>Ecolab Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ecl#NYSE">ECL</a>) dropped 9% to close at $142.98 after the company reported worse-than-expected Q3 EPS results.</li>
<li>TopBuild Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bld#NYSE">BLD</a>) dropped 7.6% to close at $157.18 following Q3 results.</li>
<li>Kforce Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kfrc#NASDAQ">KFRC</a>) fell 7.5% to close at $58.53 after reporting Q3 results.</li>
<li>Avis Budget Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/car#NASDAQ">CAR</a>) fell 6.7% to close at $220.52 following Q3 results.</li>
<li>Sealed Air Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/see#NYSE">SEE</a>) dipped 6.7% to close at $44.42 after the company announced it will acquire Liquibox for $1.15 billion. The company also reported worse-than-expected Q3 sales.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) dropped 6.4% to close at $3.49.</li>
<li>Babcock &amp; Wilcox Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bw#NYSE">BW</a>) fell 4.8% to close at $4.34.</li>
<li>Stryker Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/syk#NYSE">SYK</a>) fell 4% to close at $220.09 after the company reported worse-than-expected Q3 results and issued 2022 guidance below estimates.</li>
</ul>

Press Releases

Mill City Ventures III, Ltd. Reports 2024 First Quarter Results

Mill City Ventures III, Ltd. Reports 2024 Second Quarter Financial Results

Mill City Ventures III, Ltd. Advances $1.15 Million To Award-winning Senior Care Provider

Mill City Ventures III, Ltd. Advances $2 Million To Award-Winning Holiday Light Maze Experience

Mill City Announces Stock Repurchase Program

Mill City Ventures III, Ltd. Reports 2024 Third Quarter Financial Results

Mill City Ventures III, Ltd Commits $3M for Twin Cities Senior Care Provider

Mill City Ventures III, Ltd. Announces Select  2024 Short-term Loan Portfolio Data

Mill City Ventures III, Ltd. Announces Amendment to Loan Agreement with Mustang Funding, LLC

Comments

Mill City Ventures III

Mill City Ventures III (MCVT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga